Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07444515

Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We propose the following hypotheses: * The use of herbal medicine is common among patients with chronic kidney disease in Réunion island. * This use could influence the progression of kidney disease in these patients. To assess the primary inclusion criterion, patients will be easily identified by nephrologists through existing follow-up. The questionnaires will be administered after this early identification by the investigators at each center. The primary evaluation criterion is straightforward: it aims to establish an overview of the use of herbal medicine in our patient population. This information is currently unavailable and remains crucial for measuring the extent of the issue. Our secondary criteria will involve more in-depth analysis of this use and an attempt to correlate the use of certain herbs with the rate of progression of kidney disease at one year. We targeted patients with moderate to end-stage chronic kidney disease (KDIGO classification 3 to 5), which are the stages typically included in kidney disease studies. Furthermore, these patients are the most likely to experience a greater annual progression of their kidney disease, and the effect of herbs on this progression could be investigated. Transplant patients were not included because they are more aware of the risks of not using herbal medicine due to their use of immunosuppressants.

Conditions

Interventions

TypeNameDescription
OTHERseries of questions which can change patient careSeries of question are about self medication with plants

Timeline

Start date
2026-04-02
Primary completion
2028-04-02
Completion
2028-07-02
First posted
2026-03-03
Last updated
2026-03-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07444515. Inclusion in this directory is not an endorsement.